Cargando…

Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation

BACKGROUND AND AIM: Elobixibat is a locally acting inhibitor of the ileal bile acid transporter. We compared bile acid metabolism between healthy subjects and patients with chronic constipation and assessed changes in the bile acid profile after elobixibat administration in the latter group. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakajima, Atsushi, Ishizaki, Sonoko, Matsuda, Kazuki, Kurosu, Shinsuke, Taniguchi, Shinya, Gillberg, Per‐Göran, Mattsson, Jan P, Hasunuma, Tomoko, Camilleri, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles ‐ Gastroenterology (Clinical)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311197/ https://www.ncbi.nlm.nih.gov/pubmed/35168298 http://dx.doi.org/10.1111/jgh.15800

Ejemplares similares

Efficacy, long‐term safety, and impact on quality of life of elobixibat in more severe constipation: Post hoc analyses of two phase 3 trials in Japan
por: Nakajima, Atsushi, et al.
Publicado: (2019)

Elobixibat improves rectal sensation in patients with chronic constipation aged ≥60 years: a randomised placebo-controlled study
por: Manabe, Noriaki, et al.
Publicado: (2023)

Effects of Elobixibat in Patients with Diabetes and Concomitant Chronic Constipation: an 8-week, Prospective, Single-center, Single-arm Study
por: Hishida, Yoshiaki, et al.
Publicado: (2022)

Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation
por: Tanaka, Kosuke, et al.
Publicado: (2022)

Treatment of Chronic Constipation using Elobixibat in a Real-World Setting: A Retrospective Cohort Study using an Electronic Medical Records Database in Japan
por: Masaki, Hisanori, et al.
Publicado: (2023)

Characteristics of the Contrast Enema Do Not Predict an Effective Bowel Management Regimen for Patients with Constipation or Fecal Incontinence
por: Huber, Jordan, et al.
Publicado: (2016)

Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial
por: Nakajima, Atsushi, et al.
Publicado: (2017)

Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake
por: Ozaki, Anna, et al.
Publicado: (2021)

Rectosigmoid Adenocarcinoma Presenting As Nine Days of Constipation
por: Thota, Sri Sai Prasanna, et al.
Publicado: (2023)

Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study
por: Kamei, Daigo, et al.
Publicado: (2020)

Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial
por: Kumagai, Yuji, et al.
Publicado: (2018)

The Efficacy and Safety of Elobixibat for the Elderly with Chronic Constipation: A Multicenter Retrospective Cohort Study
por: Tomie, Akira, et al.
Publicado: (2020)

Faecal Incontinence and Constipation
por: McFarlane, X A, et al.
Publicado: (1997)

Safety and Efficacy of Elobixibat, an Ileal Bile Acid Transporter Inhibitor, in Elderly Patients With Chronic Idiopathic Constipation According to Administration Time: Interim Analysis of Post-marketing Surveillance
por: Nakajima, Atsushi, et al.
Publicado: (2022)

Long-Term Outcomes of Antegrade Continence Enemas to Treat Constipation and Fecal Incontinence in Children
por: Baaleman, Desiree F., et al.
Publicado: (2023)

Prevalence of suspected child abuse in children with constipation: a case–control study
por: Vriesman, Mana H, et al.
Publicado: (2022)

Efficacy and Safety of Elobixibat in Elderly Patients with Chronic Constipation: A Single-center, Observational Study
por: Abe, Tatsuya, et al.
Publicado: (2020)

Effects of Elobixibat on Constipation and Lipid Metabolism in Patients With Moderate to End-Stage Chronic Kidney Disease
por: Matsuyama, Momoko, et al.
Publicado: (2022)

Correction to: Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake
Publicado: (2023)

Poor Sleep Quality as a Risk Factor for Constipation Among Community-Dwelling Older Adults in Japan
por: Nakagawa, Hiroaki, et al.
Publicado: (2023)

Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson’s disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group study (CONST-PD)
por: Hatano, Taku, et al.
Publicado: (2022)

Acupuncture for functional constipation: protocol of an individual patient data meta-analysis
por: Zheng, Qianhua, et al.
Publicado: (2015)

Uncontrolled, Open-Label Pre-Dinner Administration of Elobixibat in Japanese Adults with Chronic Constipation: A Retrospective Chart Review
por: Odaka, Takeo, et al.
Publicado: (2020)

Efficacy and safety of inulin supplementation for functional constipation: a systematic review protocol
por: Liu, Xinyuan, et al.
Publicado: (2021)

Biofeedback Therapy in Constipation and Fecal Incontinence
por: Myung, Seung-Jae
Publicado: (2010)

Different doses of prucalopride in treating chronic idiopathic constipation: a meta-analysis and Bayesian analysis
por: Yang, Tao, et al.
Publicado: (2021)

Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipation
por: Yamamoto, Atsushi, et al.
Publicado: (2022)

The Effect of Education Given to Children with Functional Constipation and Fecal Incontinence and Their Mothers on Anxiety and Constipation Management
por: Yıldırım, Arzu, et al.
Publicado: (2020)

What’s New in the Toolbox for Constipation and Fecal Incontinence?
por: Lee, Yeong Yeh
Publicado: (2014)

Fecal Microbiota and Diet of Children with Chronic Constipation
por: de Moraes, Joyce Gomes, et al.
Publicado: (2016)

Potential role of fecal microbiota in patients with constipation
por: Tian, Yan, et al.
Publicado: (2020)

Safety of Lubiprostone in Pediatric Patients With Functional Constipation: A Nonrandomized, Open-Label Trial
por: Hussain, Sunny Z., et al.
Publicado: (2021)

Incidence of constipation and associated factors in the period of lockdown during COVID-19 pandemic: protocol for a systematic review and meta-analysis
por: Zhang, Juan Juan, et al.
Publicado: (2023)

On the prevalence of constipation and fecal incontinence, and their co-occurrence, in the Netherlands
por: Meinds, Rob J., et al.
Publicado: (2016)

Current Applications of Fecal Microbiota Transplantation in Functional Constipation
por: Liu, Qi-Hong, et al.
Publicado: (2022)

Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease
por: Kessoku, Takaomi, et al.
Publicado: (2020)

Parent-child Agreement on Health-Related Quality of Life in Children With Functional Constipation in Primary Care
por: van Summeren, Jojanneke J.G.T., et al.
Publicado: (2018)

Constipation in Patients With Chronic Kidney Disease
por: Cha, Ra Ri, et al.
Publicado: (2023)

Abnormal bile acid metabolism is an important feature of gut microbiota and fecal metabolites in patients with slow transit constipation
por: Fan, Yadong, et al.
Publicado: (2022)

Multicentre, non-interventional study of the efficacy and tolerability of linaclotide in the treatment of irritable bowel syndrome with constipation in primary, secondary and tertiary centres: the Alpine study
por: Pohl, Daniel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n2skjrf4cr3ilu11jo4i4vva3d